sub:provenance {
sub:assertion dcterms:description "[Stratification by tumor site indicated that the GSTM3 polymorphism was associated with a decreased risk of laryngeal cancer under recessive model and homozygote comparison (OR?=?0.52, 95%CI: 0.30-0.89; and OR?=?0.50, 95%CI: 0.29-0.87, respectively); By stratifying source of control, decreased cancer risk was observed in hospital-based population under all genetic models (OR?=?0.67, 95%CI: 0.56-0.81 for the dominant model; OR?=?0.66, 95%CI: 0.46-0.95 for the recessive model; OR?=?0.55, 95%CI: 0.37-0.83 for the homozygote comparison model, and OR?=?0.70, 95%CI: 0.58-0.84 for the heterozygote comparison model).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ;
wi:evidence dgn-void:source_evidence_literature ;
sio:SIO_000772 miriam-pubmed:24416175 ;
prov:wasDerivedFrom dgn-void:BEFREE ;
prov:wasGeneratedBy eco:ECO_0000203 .
dgn-void:BEFREE pav:importedOn "2017-02-19"^^
xsd:date .
dgn-void:source_evidence_literature a eco:ECO_0000212 ;
rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en ;
rdfs:label "DisGeNET evidence - LITERATURE"@en .
}